Although the incidence of Pneumocystis pneumonia (PCP) has decreased since the
introduction of combination antiretroviral therapy, it remains an important cause of disease in …

Pneumocystis jirovecii is the opportunistic fungal organism that causes Pneumocystis
pneumonia (PCP) in humans. Similar to other opportunistic pathogens, Pneumocystis …

Host defenses are profoundly compromised in HIV-infected hosts due to progressive
depletion of CD4+ T lymphocytes. Moreover, deficient CD4+ T lymphocytes impair …

For individuals who are immunocompromised, the opportunistic fungal pathogen
Pneumocystis jirovecii is capable of causing life-threatening pneumonia as the causative …

Pneumocystis pneumonia (PcP) in humans is caused by Pneumocystis jirovecii, which has
recently been reclassified as a fungus because its cell wall composition and nucleotide …

The innate immune response to Pneumocystis infection is not well understood. In this study,
normal C57BL/6 mouse alveolar macrophages were found to respond to Pneumocystis …

Background. The ubiquitous opportunistic pathogen Pneumocystis jirovecii causes
pneumonia in immunocompromised individuals, including human immunodeficiency virus …

Pulmonary colonization by the opportunistic pathogen Pneumocystis jiroveci is common in
HIV+ subjects and has been associated with development of chronic obstructive pulmonary …

Pneumocystis pneumonia (PCP) is an opportunistic, infectious disease that is prevalent in
immunosuppressed hosts. Corticosteroid treatment is the most significant risk factor for …

Many therapeutic options exist for the treatment of Pneumocystis carinii pneumonia, a
common fungal opportunistic pulmonary pathogen, but treatment is often complicated by …